October 18, 2023
“Postmenopausal women with hormone receptor-positive breast cancer and obesity who are treated with aromatase inhibitors at are increased risk of having a recurrence of their disease,” said study author Sixten Harborg, a researcher in the department of oncology at Aarhus University Hospital in Denmark
Read the Full article
Tags: